Marijuana Company of America, Inc. (MCOA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Marijuana Company of America, Inc. (MCOA) with AI Score 42/100 (Weak). Marijuana Company of America, Inc. develops and distributes cannabis and CBD products under the hempSMART brand. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Marijuana Company of America, Inc. (MCOA) Healthcare & Pipeline Overview
Marijuana Company of America, Inc. focuses on developing and distributing cannabis and CBD products under the hempSMART brand, targeting the wellness market through online and affiliate channels, while facing significant challenges in profitability and market competition within the specialty drug manufacturing sector.
Investment Thesis
Investing in Marijuana Company of America, Inc. presents significant risks due to its negative profitability and high beta of 9.91, indicating extreme volatility relative to the market. The company's negative profit margin of -1441.1% and gross margin of -74.1% raise concerns about its financial sustainability. Growth depends on successful expansion of the hempSMART product line and effective marketing strategies to increase sales through online and affiliate channels. Potential investors should carefully consider the risks associated with OTC-listed companies and the competitive landscape of the cannabis and CBD market. The company's small size, with only 7 employees, also poses operational challenges.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- P/E ratio of -0.09 reflects negative earnings and challenges in achieving profitability.
- Profit margin of -1441.1% highlights significant losses and operational inefficiencies.
- Gross margin of -74.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's business model.
- Beta of 9.91 suggests extreme volatility compared to the broader market, making it a high-risk investment.
Competitors & Peers
Strengths
- Established hempSMART brand.
- Proprietary formulations like hempSMART Brain.
- Distribution network through cdistro.com.
- Direct-to-consumer sales channel.
Weaknesses
- Negative profitability and gross margins.
- High beta indicating extreme volatility.
- Limited financial resources.
- Small employee base.
Catalysts
- Upcoming: Potential legalization of cannabis at the federal level in the U.S., which could significantly expand the market for MCOA's products.
- Ongoing: Expansion of the hempSMART product line to include new formulations and delivery methods.
- Ongoing: Strategic partnerships and distribution agreements to increase market reach.
- Ongoing: Enhanced e-commerce and digital marketing efforts to drive online sales.
- Ongoing: International expansion into legal cannabis markets.
Risks
- Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.
- Potential: Complex and evolving regulatory landscape, which could impact MCOA's ability to operate and sell its products.
- Potential: Fluctuations in consumer demand for cannabis and CBD products.
- Potential: Potential for product recalls or safety concerns, which could damage MCOA's brand reputation.
- Ongoing: Negative profitability and gross margins, which could threaten MCOA's financial sustainability.
Growth Opportunities
- Expansion of hempSMART Product Line: MCOA has the opportunity to expand its hempSMART product line to cater to a broader range of consumer needs. By introducing new formulations and delivery methods, such as edibles or topicals, MCOA can attract new customers and increase sales. The global CBD market is projected to reach $16 billion by 2028, providing a substantial market opportunity for MCOA to capitalize on. This expansion requires investment in research and development and effective marketing strategies.
- Strategic Partnerships and Distribution Agreements: MCOA can pursue strategic partnerships and distribution agreements to expand its reach and access new markets. Collaborating with established retailers or distributors can provide MCOA with access to a wider customer base and increase brand awareness. The company can also explore partnerships with healthcare providers or wellness centers to promote its products. These partnerships can be established within the next 1-2 years, driving revenue growth and market penetration.
- International Expansion: MCOA can explore international expansion opportunities in countries where cannabis and CBD products are legal. By entering new markets, MCOA can diversify its revenue streams and reduce its reliance on the U.S. market. The European CBD market, for example, is experiencing rapid growth, presenting a significant opportunity for MCOA. This expansion will require careful consideration of regulatory requirements and market dynamics in each country.
- Focus on E-commerce and Digital Marketing: MCOA can enhance its e-commerce platform and digital marketing efforts to drive online sales. By optimizing its website for search engines and investing in targeted advertising campaigns, MCOA can attract more customers and increase conversion rates. The company can also leverage social media platforms to engage with customers and build brand awareness. These digital strategies can be implemented within the next 6-12 months, leading to increased online sales and customer engagement.
- Development of Proprietary Formulations and Intellectual Property: MCOA can invest in research and development to create proprietary formulations and intellectual property for its products. By developing unique and differentiated products, MCOA can establish a competitive advantage and protect its market share. The company can also seek patents for its formulations and technologies, further strengthening its intellectual property portfolio. This long-term strategy can enhance MCOA's brand reputation and attract investors.
Opportunities
- Expansion of hempSMART product line.
- Strategic partnerships and distribution agreements.
- International expansion into legal cannabis markets.
- Enhanced e-commerce and digital marketing efforts.
Threats
- Intense competition in the cannabis and CBD market.
- Complex and evolving regulatory landscape.
- Fluctuations in consumer demand.
- Potential for product recalls or safety concerns.
Competitive Advantages
- Brand recognition of hempSMART products.
- Proprietary formulations, including hempSMART Brain.
- Established distribution network through cdistro.com.
- Affiliate marketing program driving sales.
About MCOA
Marijuana Company of America, Inc. (MCOA) was founded in 1985 as Converge Global, Inc., before rebranding in December 2015 to capitalize on the emerging cannabis and CBD market. The company develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand within the United States. MCOA's product line includes hempSMART Brain, a patented personal care product for brain wellness; hempSMART Pain capsules and cream for discomfort relief; hempSMART Drops, a hemp CBD oil tincture; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, a powderized CBD drink. These products are primarily sold through the company's website and affiliate marketing programs. Additionally, MCOA distributes hemp and CBD products, including smoke and vape shop related items, to wholesalers, c-stores, specialty retailers, and consumers through its cdistro.com platform. Headquartered in Los Angeles, California, MCOA aims to establish a presence in the growing CBD and cannabis wellness market.
What They Do
- Develops and produces cannabis and cannabidiol (CBD) products.
- Distributes products under the hempSMART brand.
- Offers hempSMART Brain for brain wellness.
- Provides hempSMART Pain capsules and cream for discomfort relief.
- Sells hempSMART Drops, a hemp CBD oil tincture.
- Markets hempSMART Pet Drops for cats and dogs.
- Offers hempSMART Face, a facial moisturizer.
- Distributes hemp and CBD products through www.cdistro.com.
Business Model
- Develops and manufactures hempSMART branded CBD and cannabis products.
- Sells products directly to consumers through its website.
- Distributes products through affiliate marketing programs.
- Wholesales hemp and CBD products to retailers via cdistro.com.
Industry Context
Marijuana Company of America, Inc. operates in the rapidly evolving cannabis and CBD market, which is characterized by increasing consumer demand for wellness products. The industry is highly competitive, with numerous companies vying for market share. MCOA faces competition from established players and emerging brands. The regulatory landscape is complex and varies by state, creating both opportunities and challenges for companies in this sector. The global cannabis market is projected to reach significant growth in the coming years, driven by increasing legalization and acceptance of cannabis and CBD products.
Key Customers
- Individual consumers seeking wellness and pain relief products.
- Retailers, including smoke shops, vape shops, and c-stores.
- Wholesalers distributing hemp and CBD products.
- Affiliate marketers promoting hempSMART products.
Financials
Chart & Info
Marijuana Company of America, Inc. (MCOA) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Feb 28, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MCOA.
Price Targets
Wall Street price target analysis for MCOA.
MoonshotScore
What does this score mean?
The MoonshotScore rates MCOA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jesus Quintero
CEO
Jesus Quintero serves as the CEO of Marijuana Company of America, Inc. His background includes experience in managing and developing businesses, with a focus on the cannabis and CBD industry. He has been instrumental in guiding the company's strategic direction and product development efforts. His expertise lies in identifying market opportunities and building partnerships to expand the company's reach. He is responsible for overseeing all aspects of the company's operations, from product development to sales and marketing.
Track Record: Under Jesus Quintero's leadership, Marijuana Company of America, Inc. has focused on expanding its hempSMART product line and establishing a presence in the competitive CBD market. Key milestones include the development of hempSMART Brain and the expansion of the company's online sales channels. He has also focused on building relationships with affiliate marketers to drive sales and increase brand awareness. His tenure has been marked by efforts to navigate the evolving regulatory landscape and position the company for growth.
MCOA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Company of America, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and increased volatility. This tier is often populated by shell companies, companies in distress, or those with minimal operations.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and potential for lack of transparency.
- Low trading volume and illiquidity.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight and investor protection.
- Potential for delisting or suspension of trading.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Check for any regulatory actions or legal issues.
- Established hempSMART brand.
- Online presence and direct-to-consumer sales channel.
- Distribution network through cdistro.com.
- Management team in place.
Common Questions About MCOA
What does Marijuana Company of America, Inc. do?
Marijuana Company of America, Inc. (MCOA) develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand. The company's product line includes personal care products, pain relief capsules and creams, CBD oil tinctures, pet products, and drink mixes. These products are sold through the company's website, affiliate marketing programs, and wholesale distribution channels. MCOA aims to capitalize on the growing demand for CBD and cannabis-based wellness products in the United States and potentially international markets.
What do analysts say about MCOA stock?
As of 2026-03-17, there is no available analyst coverage for Marijuana Company of America, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-0.09), profit margin (-1441.1%), and gross margin (-74.1%) indicate significant financial challenges. Potential investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC-listed companies with limited financial information.
What are the main risks for MCOA?
The main risks for Marijuana Company of America, Inc. include intense competition in the cannabis and CBD market, complex and evolving regulations, fluctuations in consumer demand, and potential product recalls. The company's negative profitability and gross margins pose a significant threat to its financial sustainability. Additionally, its OTC listing and limited financial disclosure increase the risk of fraud or manipulation. Investors should carefully consider these risks before investing in MCOA.
What are the key factors to evaluate for MCOA?
Marijuana Company of America, Inc. (MCOA) currently holds an AI score of 42/100, indicating low score. Key strength: Established hempSMART brand.. Primary risk to monitor: Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.. This is not financial advice.
How frequently does MCOA data refresh on this page?
MCOA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MCOA's recent stock price performance?
Recent price movement in Marijuana Company of America, Inc. (MCOA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established hempSMART brand.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MCOA overvalued or undervalued right now?
Determining whether Marijuana Company of America, Inc. (MCOA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MCOA?
Before investing in Marijuana Company of America, Inc. (MCOA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC listing.
- Financial data may not be fully reliable.
- AI analysis pending.